Search hospitals > Illinois > Harvey
Ingalls Memorial Hospital
Claim this profileHarvey, Illinois 60426
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
267 reported clinical trials
5 medical researchers
Summary
Ingalls Memorial Hospital is a medical facility located in Harvey, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Ingalls Memorial Hospital is involved with conducting 267 clinical trials across 403 conditions. There are 5 research doctors associated with this hospital, such as Mark F. Kozloff, Ivy Abraham, Danielle Sterrenberg, MD, and James A. Wallace.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Mark F. KozloffIngalls Memorial Hospital5 years of reported clinical research
Studies Cancer
Studies Colorectal Cancer
26 reported clinical trials
77 drugs studied
Ivy AbrahamIngalls Memorial Hospital1 year of reported clinical research
Studies Cancer
Studies Breast Cancer
12 reported clinical trials
25 drugs studied
Danielle Sterrenberg, MDIngalls Memorial Hospital6 years of reported clinical research
Studies Breast Cancer
Studies Cancer
9 reported clinical trials
18 drugs studied
James A. WallaceIngalls Memorial Hospital3 years of reported clinical research
Studies Cancer
Studies Lung Cancer
10 reported clinical trials
42 drugs studied
Clinical Trials running at Ingalls Memorial Hospital
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Nasopharyngeal Cancer
Colorectal Cancer
Lung Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Ingalls Memorial Hospital?
Ingalls Memorial Hospital is a medical facility located in Harvey, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Ingalls Memorial Hospital is involved with conducting 267 clinical trials across 403 conditions. There are 5 research doctors associated with this hospital, such as Mark F. Kozloff, Ivy Abraham, Danielle Sterrenberg, MD, and James A. Wallace.